Significantly JAK2 has been implicated in interleukin (IL)-6-dependent breast cancer stem cell self-renewal [11], and in both IL-6- and IL-8-dependent growth of triple-negative breast cancers (TNBCs) [12]. This evidence concerns the gene JAK2 and breast carcinoma.